Hopital du Sacre-Coeur de Montreal

Montreal, Quebec QC H4J 1C5

2 studies enrolling now · 50 studies all time

What they study most

Acute Spinal Cord Injury, Acute Spinal Paralysis, Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Anemia, Angioplasty, Transluminal, Percutaneous Coronary, Asthma, Atherosclerosis, AtrioVentricular Nodal Reentrant Tachycardia, B-cell Chronic Lymphocytic Leukemia, Bladder Cancer, Breast Cancer, Breast Carcinoma In Situ

Studies at this site

• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients — Running, not enrolling
• Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer — Running, not enrolling
• Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations — Running, not enrolling
• Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — Completed
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
• A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease — Completed
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Completed
• A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis — Stopped early
• Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery — Running, not enrolling
• Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia — Completed
• Evaluation of the Phased Radio Frequency Ablation System — Stopped early
• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) — Completed
• Absorb IV Randomized Controlled Trial — Completed
• Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study — Status unconfirmed
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ — Completed
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
• E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes — Completed
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma — Completed
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer — Completed
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer — Completed
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
• Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism — Completed
• Genetic Study in Patients With Stage II or Stage III Colon Cancer — Completed
• A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries — Completed
• Bosutinib For Autosomal Dominant Polycystic Kidney Disease — Completed
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy — Completed
• A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma — Completed
• A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease — Completed
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia — Completed
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed
• A Study to Compare the NexGen LPS and LPS-Flex Knee Implants — Completed
• A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) — Withdrawn before enrolling
• Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
• ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed